http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5514689-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_280d87031f0c5786de1808713a1b76b7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D217-24
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-24
filingDate 1991-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1996-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81cfb8613085f631e4004dcc3c762038
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19b641d95cdd8603a9adf39df49ea6b6
publicationDate 1996-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5514689-A
titleOfInvention Cribrostatins 1 and 2
abstract The blue marine sponge Cribrochalina sp., collected in the Republic of the Maldives, was found to contain the new cell growth inhibitory isoquinolinequinones designated cribrostatin 1 (8.8x10-6% yield) and 2 (3.1x10-6% yield) which are active against the P388 lymphocytic leukemia cell line (PS ED50 1.58 mu g/mL, PS ED50 2.73 mu g/mL, respectively). Importantly, both cribrostatins 1 and 2 have shown selective activity against all of the nine human melanoma cell lines employed by the U.S. National Cancer Institute. Structural determinations of both substances were accomplished utilizing high field NMR (400 MHz) and mass spectral studies. Confirmation of the cribrostatin 1 structure was achieved by X-ray crystallographic techniques.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11174291-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11629167-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004074248-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009325971-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004074248-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7317020-B2
priorityDate 1991-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4853400-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234439080
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1043
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19066652
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11718
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID251278
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229859796
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128047903
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399566
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54277805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393662
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226138
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159598
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226747433
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18980541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128151852
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4650
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232017443
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136045737
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226902847
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227796750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399817
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID349435
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57157588
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398982
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408144
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421097
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87059971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71583
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399818

Total number of triples: 52.